Seasonal malaria chemoprevention (SMC) and vitamin A supplementation (VAS) are high-impact interventions in the prevention of malaria and vitamin A deficiency, respectively, in children under five. In Nigeria, however, coverage of VAS is low. SMC, which reached 22 million children in Nigeria in 2022 alone, may offer a platform to improve VAS coverage. We conducted a qualitative study to assess the facilitators of, and barriers to, fully integrating VAS with SMC.
This poster was presented at the 71st annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: NigeriaKeywords: Community delivery | Research | Malaria | Seasonal malaria chemoprevention | SDG3
« Back to Publications